Concourse Financial Group Securities, Inc. Aziyo Biologics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share
Q1 2025 May 14, 2025	BUY	N/A
Q4 2024 Feb 13, 2025	BUY	N/A
Q3 2024 Oct 10, 2024	BUY	N/A
Q2 2024 Jul 23, 2024	BUY	N/A
Q1 2024 Apr 30, 2024	BUY	N/A
Q4 2023 Feb 07, 2024	BUY	$1.14 - $1.45 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.13 - $2.52 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.13 - $2.52 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.41 - $2.79 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.19 - $4.96 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$3.48 - $8.94 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$5.72 - $7.76 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$5.75 - $7.41 $0 - $0
Q1 2022 May 09, 2022	BUY	$4.31 - $7.58 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$4.1 - $6.82 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$6.75 - $9.52 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$9.51 - $13.97 $0 - $0
Q1 2021 May 13, 2021	BUY	$13.08 - $16.41 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$10.77 - $14.82 $0 - $0

Others Institutions Holding AZYO

# of Institutions

Shares Held

17.2M

Call Options Held

Put Options Held

Aigh Capital Management LLC Baltimore, MD

3.38M
Shares

$4.9 Million
2.64% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

3.18M
Shares

$4.62 Million
0.21% of portfolio
Silverarc Capital Management, LLC

2.67M
Shares

$3.87 Million
0.94% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

2.64M
Shares

$3.83 Million
0.02% of portfolio
Birchview Capital, LP Burlington, VT

1.19M
Shares

$1.72 Million
1.55% of portfolio

View Full List

About AZIYO BIOLOGICS, INC.

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

More about AZYO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account